Publication at Second Faculty of Medicine |
2020
Abstract
Infantile hemangioma (IH) occurs in 5 to 10 % of children under one year of age. This benign vascular tumor is characterized by three phases of growth - proliferation, plateau, involution.
Superficial hemangiomas reach their maximum size in 6 to 8 months, in deep ones rarely up to 2 years. Modern non-selective β-blocker therapy - propranolol - offers children an effective, safe and non-invasive solution.
Starting the therapy in the proliferative phase is crucial for effectiveness.